Petrosonic Energy (PSON) 0.0052 $PSON Petrosonic Energy,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Petrosonic Energy (PSON) 0.0052 $PSON

Petrosonic Energy, Inc. Adds New President and COO to Its Leadership Team
GlobeNewswire - Thu Dec 03, 7:47AM CST
Petrosonic Energy (OTCSON) reported today that Keith R. McGee will become the company's President and Chief Operating Officer (COO) effective immediately. Mr. McGee, who is a principal at RockReef Advisors, LLC., has recently been advising the company regarding business planning and funding the commercialization of Petrosonic's Sonoprocess(TM) for advanced separation applications in the oil and gas industry.
MS: 25.69 (+0.54)

Oil and Gas Industry Veteran to Lead Petrosonic Technology Effort
eTeligis - Tue Jun 09, 1:56PM CDT
CALGARY, ALBERTA, Canada, via ETELIGIS INC., 06/09/2015 - - Petrosonic (OTC Pink: PSON) (PINKSHEETS: PSON) reported today that Gerald Bruce will become the company's Chief Technology Officer (CTO) effective immediately. Mr. Bruce, who is a principal at GWB Consulting Inc., has been advising the company for several months regarding commercialization of Petrosonic's Sonoprocess technology in several segments of the oil and gas industry.

Petrosonic Energy, Inc. Receives Confirmation on Excise Tax for its SFO Manufacturing in Albania
eTeligis - Mon Jan 12, 8:11PM CST
CALGARY, AB, Canada, via ETELIGIS INC., 01/12/2015 - - Petrosonic Energy, Inc. (OTCQB: PSON), an emerging leader in heavy oil upgrading and related technologies, announced today that the Albanian Parliament passed the fiscal year 2015 law on December 26, 2014, thus, resolving the level of excise tax issue for the synthetic fuel oil (SFO) that the company manufactures in Albania. This very important step allows the company to begin processing SFO from its 3,000 barrels per day heavy crude emulsion process plant and start generating revenue beginning 1st Quarter of 2015.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Angel Oak Mortgage Trust 2025-1 Receives Preliminary Ratings

Updated Category News Views 195

Angel Oak Mortgage Trust 2025-1 Ratings Overview KBRA has recently assigned preliminary ratings to various classes of mortgage-backed certificates associated with Angel Oak Mortgage Trust 2025-1 (AOMT 2025-1). This substantial transaction amounts to $342.0 million and comprises non-prime residential mortgage-backed securities (RMBS). It encompasses a pool of 631...

Continue Reading
Eagle Bancorp Montana Reports Positive Q3 Performance Growth

Updated Category News Views 177

Eagle Bancorp Montana's Strong Q3 Earnings Report Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), the parent entity of Opportunity Bank of Montana, recently shared its financial results for the latest quarter. With net income reaching $2.7 million, or $0.34 per diluted share, this marks an upward trend from the previous quarter’s income of $1.7 million, equivalent to $0.22...

Continue Reading
Consumer Resilience Fuels Bank of America Amidst Slowing Trends

Updated Category News Views 310

Bank of America's Performance Overview Bank of America (NYSE: BAC) has reported a mixed performance in recent times, showing resilience in its earnings even as some sectors experience challenges. The bank's stock opened slightly higher, reflecting a cautious optimism in the market with shares trading around $46.50. For the quarter, Bank of America generated $26.6 billion...

Continue Reading
The Setai St. Maarten: A New Era in Caribbean Luxury

Updated Category News Views 136

The Setai St. Maarten: A Feast for the Senses In a stunning location along the coast, The Setai St. Maarten emerges as a jewel of luxury, introducing a captivating blend of elegance and tranquility to the Caribbean. This exciting new resort is poised to redefine the standards of Caribbean hospitality, creating unforgettable experiences for guests in a picturesque coastal...

Continue Reading
Cullinan Therapeutics Gears Up for Major Healthcare Events

Updated Category News Views 142

Cullinan Therapeutics Hosts Exciting Events at Major Conferences CAMBRIDGE, Mass. — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a prominent biopharmaceutical firm, is set to engage the investment community with notable events at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting and the Jefferies 2025 Global Healthcare Conference. These gatherings...

Continue Reading